FDA Clearance Tracker · K040373
KERATO ANALYZER (EKA)
Last checked: Nov 20, 2026Latest source record: Mar 19, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Mar 19, 2004
Substantially Equivalent
Time to decision
31 days
Received Feb 17, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K040373
- Device name
- KERATO ANALYZER (EKA)
- Applicant
- Konan Medical, Inc.
- Applicant location
- Hasbrouck Heights, NJ
- Received
- Feb 17, 2004
- Decided
- Mar 19, 2004
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Microscope, Specular (NQE)
- Device class
- Class II
- Regulation
- 21 CFR 886.1850
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NQE (Microscope, Specular).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K040373
- The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Konan Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CellChek 20 rc510(k)
K203244 · Decided Jun 15, 2021 · 224 days after receipt
Device type: System, Image Management, Ophthalmic (NFJ) · Radiology & Imaging
K191558 · Decided Mar 26, 2020 · 288 days after receipt
Device type: Microscope, Specular (NQE) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.